These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6153847)

  • 21. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis.
    Thein DJ; Hurt WC
    Oral Surg Oral Med Oral Pathol; 1984 Dec; 58(6):659-66. PubMed ID: 6438572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Yellow fever vaccination as prophylaxis of herpes labialis].
    Møller A; Andersen PL; Korsager B; Black FT
    Ugeskr Laeger; 1997 Apr; 159(15):2228-9. PubMed ID: 9148548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on short-course intermittent and prevention therapies for herpes labialis.
    Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
    Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of lysine treatment in recurrent herpes simplex labialis.
    Milman N; Scheibel J; Jessen O
    Lancet; 1978 Oct; 2(8096):942. PubMed ID: 81954
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical ether and herpes simplex labialis.
    Guinan ME; MacCalman J; Kern ER; Overall JC; Spruance SL
    JAMA; 1980 Mar; 243(10):1059-61. PubMed ID: 6243714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive therapy of herpes labialis associated with trigeminal surgery.
    Schädelin J; Schilt HU; Rohner M
    Am J Med; 1988 Aug; 85(2A):46-8. PubMed ID: 3044092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
    Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
    J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of oral inosiplex treatment of recurrent herpes simplex virus infections.
    Kalimo KO; Joronen IA; Havu VK
    Arch Dermatol; 1983 Jun; 119(6):463-7. PubMed ID: 6190441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
    Morrel EM; Spruance SL; Goldberg DI;
    Clin Infect Dis; 2006 Aug; 43(4):460-7. PubMed ID: 16838235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical treatment of herpes labialis with chloroform.
    Taylor CA; Hendley JO; Greer KE; Gwaltney JM
    Arch Dermatol; 1977 Nov; 113(11):1550-2. PubMed ID: 931393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root.
    Pazin GJ; Armstrong JA; Lam MT; Tarr GC; Jannetta PJ; Ho M
    N Engl J Med; 1979 Aug; 301(5):225-30. PubMed ID: 221812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of the clinical activity of a gel combining monocaprin and doxycycline: a novel treatment for herpes labialis.
    Skulason S; Holbrook WP; Thormar H; Gunnarsson GB; Kristmundsdottir T
    J Oral Pathol Med; 2012 Jan; 41(1):61-7. PubMed ID: 21535163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tromantadine hydrochloride in the treatment of herpes simplex. Results of a double-blind therapeutic trial and an open prophylactic investigation.
    Hellgren L; Hermann LS
    Dermatologica; 1983; 167(5):267-72. PubMed ID: 6360739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled study to test the efficacy of topical 2-hydroxypropyl-Beta-cyclodextrin in the prophylaxis of recurrent herpes labialis.
    Senti G; Iannaccone R; Graf N; Felder M; Tay F; Kündig T
    Dermatology; 2013; 226(3):247-52. PubMed ID: 23816977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent herpes labialis: a pilot study of the efficacy of zinc therapy.
    Femiano F; Gombos F; Scully C
    J Oral Pathol Med; 2005 Aug; 34(7):423-5. PubMed ID: 16011612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of herpes simplex labialis.
    Spruance SL; Kriesel JD
    Herpes; 2002 Dec; 9(3):64-9. PubMed ID: 12470603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical double-blind trial of topical zinc sulfate for herpes labialis recidivans].
    Kneist W; Hempel B; Borelli S
    Arzneimittelforschung; 1995 May; 45(5):624-6. PubMed ID: 7612066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Labial herpes in patients with affective disorders receiving long-term lithium carbonate].
    Rybakowski J; Strzyzewski W; Zelechowska-Ruda E; Chłopocka-Woźniak M
    Pol Tyg Lek; 1993 Mar 1-8; 48(9-10):215-7. PubMed ID: 8234051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.